Targeted regulation of imprinted genes by synthetic zinc-finger transcription factors

Gene Therapy

Volumn 10, Issue 6, 2003, Pages 513-522

  Jouvenot, Y ^a   Ginjala, V ^b   Zhang, L ^a   Liu, P Q ^a   Oshimura, M ^c   Feinberg, A P ^d   Wolffe, A P ^e   Ohlsson, Rolf ^b   Gregory, P D ^a  

^a SANGAMO BIOSCIENCES INC   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c TOTTORI UNIVERSITY   (Japan)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

Gene regulation; Imprinting; Transcriptional repression; Zinc finger proteins

Indexed keywords

SOMATOMEDIN B; ZINC FINGER PROTEIN;

ANIMAL CELL; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE DELIVERY SYSTEM; GENE REPRESSION; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENOME IMPRINTING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SILENT GENE; TRANSCRIPTION REGULATION; VALIDATION PROCESS;

BECKWITH-WIEDEMANN SYNDROME; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GENETIC ENGINEERING; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; KIDNEY NEOPLASMS; MALE; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; WILMS TUMOR; ZINC FINGERS;

ANIMALIA; MAMMALIA;

EID: 0344284577     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301930     Document Type: Review

References (53)

1. Feinberg A, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89-92.
2. Robertson K. DNA methylation, methyltransferases, and cancer. Oncogene 2001; 20, 3139-3155.
3. Ohlsson R et al. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Weidemann syndrome. Nature Genet 1993; 4: 94-97.
4. Giannoukakis N, Deal C, Paquette J, Goodyer C, Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nature Genet 1993; 4: 98-101.
5. Zhang Y, Tycko B. Monoallelic expression of the human H19 gene. Nature Genet 1992; 1: 40-44.
6. Rainier S et al. Relaxation of imprinted genes in human cancer. Nature 1993; 362: 747-749.
7. Ogawa O et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993; 362: 749-751.
8. Weksberg R, Shen DR, Fei YL, Song QL, Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet 1993; 5: 143-150.
9. Sun FL, Dean WL, Kelsey G, Allen ND, Reik W. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 1997; 389: 809-815.
10. Eversole-Cire P et al. Activation of an imprinted Igf 2 gene in mouse somatic cell cultures. Mol Cell Biol 1993; 13: 4928-4938.
11. Pabo CO, Peisach E, Grant RA. Design and selection of novel Cys2His2 zinc finger proteins. Annu Rev Biochem 2001; 70: 313-340.
12. Liu Q, Xia Z, Case CC. Validated zinc finger protein designs for all 16 GNN DNA triplet targets. J Biol Chem 2002; 277: 3850-3856.
13. Dreier B, Beerli RR, Segal DJ, Flippin JD, Barbas CF 3rd. Development of zinc finger domains for recognition of the 5′-ANN-3′ family of DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 2001; 276: 29466-29478.
14. Segal DJ, Dreier B, Beerli RR, Barbas CF 3rd. Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5′-GNN-3′ DNA target sequences. Proc Natl Acad Sci USA 1999; 96: 2758-2763.
15. Rebar EJ, Greisman HA, Pabo CO. Phage display methods for selecting zinc finger proteins with novel DNA-binding specificities. Methods Enzymol 1996; 267: 129-149.
16. Rebar EJ, Pabo CO. Zinc finger phage: affinity selection of fingers with new DNA-binding specificities. Science 1994; 263: 671-673.
17. Beerli RR, Segal DJ, Dreier B, Barbas CT 3rd. Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci USA 1998; 95: 14628-14633.
18. Zhang L et al. Synthetic zinc finger transcription factor action at an endogenous chromosomal site. Activation of the human erythropoietin gene. J Biol Chem 2000; 275: 33850-33860.
19. Liu PQ et al. Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. J Biol Chem 2001; 276: 11323-11334.
20. Beerli RR, Dreier B, Barbas CF 3rd. Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci USA 2000; 97: 1495-1500.
21. Bartsevich VV, Juliano RL. Regulation of the MDR1 gene by transcriptional repressors selected using peptide combinatorial libraries. Mol Pharmacol 2000; 58: 1-10.
22. Xu D, Ye D, Fisher M, Juliano RL. Selective inhibition of P-glycoprotein expression in multidrug-resistant tumor cells by a designed transcriptional regulator. J Pharmacol Exp Ther 2002; 302: 963-971.
23. Ren D, Collingwood TN, Rebar EJ, Wolffe AP, Camp HS. PPAR gamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. Genes Dev 2002; 16: 27-32.
24. Ekström TJ, Cui H, Li X, Ohlsson R. Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development 1995; 121: 309-316.
25. van Dijk MA, van Schaik FM, Bootsma HJ, Holthuizen JS. Initial charaterization of the four promoters of the human IGF II gene. Mol Cell Endocrinol 1991; 81: 81-94.
26. Vu TH, Hoffman AR. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature 1994; 371: 714-717.
27. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. Tumour-suppressor activity of H19 RNA. Nature 1993; 365: 764-767.
28. Cui H et al. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis. Cancer Res 1997; 57: 4469-4473.
29. Sap J, Munoz A, Schmitt J, Stunnenberg H, Vennstrom B. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature 1989; 340: 242-244.
30. Damm K, Thompson CC, Evans RM. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 1989; 339: 593-597.
31. Zenke M, Munoz A, Sap J, Vennstrom B, Beug H. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 1990; 61: 1035-1049.
32. Yao F, Schaffer PA. An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol 1995; 69: 6249-6258.
33. Koziczak M, Muller H, Helin K, Nagamine Y. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene. Eur J Biochem 2001; 268: 4969-4978.
34. Kiess W, Paquette J, Koepf G, Wolf E, Deal C. Proinsulin-like growth factor-II overexpression does not alter monoallelic H19 gene expression in transfected human embryonic kidney fibroblasts. Biochem Biophys Res Commun 1999; 255: 226-230.
35. Kugoh H et al. Mouse A9 cells containing single human chromosomes for analysis of genomic imprinting. DNA Res 1999; 6: 165-172.
36. Inoue J et al. Construction of 700 human/mouse A9 monochromosomal hybrids and analysis of imprinted genes on human chromosome 6. J Hum Genet 2001; 46: 137-145.
37. Thorvaldsen JL, Duran KL, Bartolomei MS. Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev 1998; 12: 3693-3702.
38. Ohlsson R, Renkawitz R, Lobanenkov V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 2001; 17: 520-527.
39. Kanduri C et al. Functional interaction of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol 2000; 10: 853-856.
40. Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 2000; 405: 482-485.
41. Hark AT et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 2000; 405: 486-489.
42. Kaffer CR et al. A transcriptional insulator at the imprinted H19/Igf2 locus. Genes Dev. 2000; 14: 1908-1919.
43. Svensson K et al. The paternal allele of the H19 gene is progressively silenced during early mouse development: the acetylation status of histones may be involved in the generation of variegated expression patterns. Development 1998; 125: 61-69.
44. Drewell RA, Goddard CJ, Thomas JO, Surani MA. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. Nucleic Acids Res 2002; 30: 1139-1144.
45. Jouvenot Y, Poirier F, Jami J, Paldi A. Biallelic transcription of Igf2 and H19 in individual cells suggests a post-transcriptional contribution to genomic imprinting. Curr Biol 1999; 9: 1199-1202.
46. Wu H, Yang WF, Barbas CF 3rd. Building zinc fingers by selection: toward a therapeutic application. Proc Natl Acad Sci USA 1995; 92: 344-348.
47. Kim JS, Pabo CO. Transcriptional repression by zinc finger peptides. Exploring the potential for applications in gene therapy. J Biol Chem 1997; 272: 29795-29800.
48. Reik A, Gregory PD, Urnov FD. Biotechnologies and therapeutics: chromatin as a target. Curr Opin Genet Dev 2002; 12: 233-242.
49. Kim JS, Pabo CO. Getting a handhold on DNA: design of polyzinc finger proteins with femtomolar dissociation constants. Proc Natl Acad Sci USA 1998; 95: 2812-2817.
50. Sadowski I, Ma J, Triezenberg S, Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature 1988; 335: 563-564.
51. Ruben SM et al. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. Science 1991; 251: 1490-1493.
52. Sap J et al. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 1986; 324: 635-640.
53. Franklin G et al. The human PDGF-B gene is regulated by cell type-specific activator and suppressor elements in the first intron. EMBO J 1991; 10: 1365-1373.